ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Sunshine Biopharma Inc

Sunshine Biopharma Inc (SBFM)

0.3037
0.0098
( 3.33% )
Updated: 11:32:12

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.3037
Bid
0.3036
Ask
0.3056
Volume
276,280
0.3025 Day's Range 0.315
0.2811 52 Week Range 64.50
Market Cap
Previous Close
0.2939
Open
0.315
Last Trade
50
@
0.3036
Last Trade Time
11:34:54
Financial Volume
$ 84,953
VWAP
0.307487
Average Volume (3m)
3,328,013
Shares Outstanding
18,945,052
Dividend Yield
-
PE Ratio
-1.26
Earnings Per Share (EPS)
-0.24
Revenue
24.09M
Net Profit
-4.51M

About Sunshine Biopharma Inc

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Show more

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Montreal, Quebec, Can
Founded
1970
Sunshine Biopharma Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker SBFM. The last closing price for Sunshine Biopharma was $0.29. Over the last year, Sunshine Biopharma shares have traded in a share price range of $ 0.2811 to $ 64.50.

Sunshine Biopharma currently has 18,945,052 shares outstanding. The market capitalization of Sunshine Biopharma is $5.57 million. Sunshine Biopharma has a price to earnings ratio (PE ratio) of -1.26.

SBFM Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0363-10.67647058820.340.34880.29236677710.31847463CS
4-0.0168-5.241809672390.32050.4680.286714937520.37074773CS
12-0.6363-67.69148936170.941.160.281133280130.64781702CS
26-23.1263-98.703798548923.4328.560.2811141750837.23844603CS
52-46.7963-99.355201698547.164.50.281171408647.57610517CS
156-274.6963-99.88956363642759870.28114461286159.56274369CS
260-274.6963-99.88956363642759870.28114461286159.56274369CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 2.71
(293.44%)
104.92M
CMAXCareMax Inc
$ 3.724
(135.70%)
39.93M
SERVServe Robotics Inc
$ 11.59
(53.51%)
101.19M
NUKKNukkleus Inc
$ 0.4232
(32.25%)
5.69M
SAVACassava Sciences Inc
$ 13.16
(30.56%)
7.24M
LGCBLinkage Global Inc
$ 3.6303
(-30.39%)
109.77k
CGBSCrown LNG Holdings Ltd
$ 1.06
(-24.82%)
1.59M
SLNASelina Hospitality PLC
$ 0.0369
(-21.99%)
34.31M
HEPAHepion Pharmaceuticals Inc
$ 0.8119
(-20.40%)
6.85M
MEDSTRxADE Health Inc
$ 11.7601
(-20.22%)
69.46k
NVDANVIDIA Corporation
$ 120.4796
(2.16%)
112.31M
NCPLNetcapital Inc
$ 0.1147
(10.29%)
106.87M
MIRAMIRA Pharmaceuticals Inc
$ 2.71
(293.44%)
104.92M
SERVServe Robotics Inc
$ 11.59
(53.51%)
101.19M
SQQQProShares UltraPro Short QQQ
$ 8.32
(-1.65%)
95.07M

SBFM Discussion

View Posts
TRUSTUNITS1000000 TRUSTUNITS1000000 6 hours ago
Unprofitable
👍️0
AKATITUS AKATITUS 6 days ago
The best place for this stock is sbfm stocktwits. Tons of pissed off people with high averages and lots of DD. Ihub and twitter are mostly quiet on sbfm
👍️0
hssbwwmp hssbwwmp 6 days ago
The July RS Info Statements (PRE 14C and DEF 14C) are no longer posted on the SBFM website or Nasdaq! Is this coincidental and/or mean anything?

https://sunshinebiopharma.com/sec-filings/

https://www.nasdaq.com/market-activity/stocks/sbfm/sec-filings?page=1&rows_per_page=14
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 week ago
Losing money, wondering if they will be profitable down the road
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 week ago
Surely sec will do something
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 week ago
TERRIBLE
💩 1
BooDog BooDog 1 week ago
Another split!! LMAO
https://ih.advfn.com/stock-market/NASDAQ/sunshine-biopharma-SBFM/stock-news/94182094/form-def-14c-other-definitive-information-statem
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 weeks ago
Interesting cash balance
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 2 weeks ago
Did the mice die
💩 1
MartinLutherKing MartinLutherKing 2 weeks ago
Let’s all hold hands and pray for RNAZ the real New hope for terminally ill cancer patients Novel Lead Therapeutic Candidate, TTX-MC138
👍️0
AKATITUS AKATITUS 2 weeks ago
Could be
We will see.
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 weeks ago
Funny face
👍️0
AKATITUS AKATITUS 2 weeks ago
🤔

https://stocktwits.com/Se7en11/message/578687676
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 weeks ago
Getting interesting, .3204 and dropping
💩 1
AKATITUS AKATITUS 3 weeks ago
Very confusing 😕

https://stocktwits.com/Invartis/message/578413188
👍️0
MKAT MKAT 3 weeks ago
I don’t understand any of this anymore.
👍️0
carusso carusso 3 weeks ago
Why are they relying on Colorado law to exclude shareholders from their decision to effect yet another Reverse Split, when their business HQ is in Ft. Lauderdale, FL?

And why a 1:60, when they only just completed a 1:100? Does the company have NO financial value at all, that these accounting tricks are necessary?

Final comment: it is nauseating when CEO’s don’t reduce their own shares, but just stick it to everybody else.

They should have agreed to be delisted from the NASDAQ, until such time as organic growth earned them a chance to rejoin it. All the verbiage about increasing liquidity, blah blah blah, rings hollow when the are reducing the OS from 24 million to 39 thousands. What a farce! Does he read his own writing?!?
👍️ 2
hssbwwmp hssbwwmp 3 weeks ago
I thought SBFM got caught doing some fishy business with the the last RS and Warrants. Whey would the Nasdaq panel allow another RS vs. delisting SBFM now?
👍️0
MKAT MKAT 3 weeks ago
https://www.sec.gov/Archives/edgar/data/1402328/000168316824004574/sunshine_pre14c.htm
👍️0
MKAT MKAT 3 weeks ago
https://www.sec.gov/Archives/edgar/data/1402328/000168316824004574/sunshine_pre14c.htm
👍️0
carusso carusso 3 weeks ago
Link, please?
👍️0
MKAT MKAT 3 weeks ago
Looks like they will be doing yet another RS after all!!! This really hurts…
👍️0
hssbwwmp hssbwwmp 3 weeks ago
Are we om for another RS or can SBFM get back over $1 some other way (see below from the 8K today)?

The last time they did a RS and Warrants seemed a bit shady and the Nasdaq was "concerned" about how they did it.

Item 8.01. Other Events.
On June 28, 2024, Sunshine Biopharma, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”), informing the Company that the Nasdaq Hearings Panel has granted the Company’s request for an exception until August 26, 2024, to regain compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2).
👍️0
AKATITUS AKATITUS 3 weeks ago
More 🍿 🍿 🍿
🤔
😄
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Made a while back
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Keeps dropping
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Shareholders post after many r s over a close tine frame
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Losing money
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Great sales
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Worst r s in history
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Dropping again
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Could this go to dollarsss
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Think no more r s
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Wow up now
💩 1
Klinsmann Klinsmann 4 weeks ago
Looks like a triple bottom holding for reverse
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Great sales
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 4 weeks ago
Keeps dropping
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
.345
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Great shorting
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Back to dropping again
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Cash balance ??????
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Wow .28
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Up 0.07 maybe reversal ???????
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Interesting company
💩 1
Tiger Money Tiger Money 1 month ago
Must be short covering day, taking gains….
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Someone posted delist ??????
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Management boo
💩 1
TRUSTUNITS1000000 TRUSTUNITS1000000 1 month ago
Dropping like crazy
💩 1
hssbwwmp hssbwwmp 1 month ago
SBFM needs to unwind all the crap deals they did with Aegis to include giving them back their money and canceling 33 Million shares!

Then, they need to get something done with their drug development pipeline.

I know this is a pipedream, but seems to be the only way to fix their mess.
👍️0
hssbwwmp hssbwwmp 1 month ago
Friday (6/14/2024) is when SBFM had to respond (in writing) to Nasdaq about the additional listing concerns (aka additional deficiency) related to the "alternate cashless exercise" of the Series A Warrants." SBFM needed to present their views about this concern.

So, did they respond? If so, what was the response? Now we wait for a decision on delisting?

From the 6/7/24 8K filing: "The letter has no immediate effect on the listing of the Company’s common stock. The letter serves as a formal notification that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market. In that regard, the letter states that the Company should present its views with respect to this additional deficiency to the Panel in writing no later than June 14, 2024."
👍️0

Your Recent History

Delayed Upgrade Clock